对三阴性乳腺癌有效的新一代 CD44v6 特异性 CAR-NK 细胞
Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer.
有必要开发针对三阴性乳腺癌(TNBC)的新有效疗法。
47.2分
★★★☆☆
FRONTIER PAPERS
Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer.
有必要开发针对三阴性乳腺癌(TNBC)的新有效疗法。
Engineering Human MAIT Cells with Chimeric Antigen Receptors for Cancer Immunotherapy.
用嵌合Ag受体(CAR)工程化免疫细胞是癌症免疫治疗中一项有前景的技术。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。